MARIA INES CALIL CURY GUIMARAES

Resultados de Busca

Agora exibindo 1 - 5 de 5

Efeito citogenetico do sup(131)I precedido por administracao de REC-HTSH em ratos wistar
2005 - SILVA, M.A.; RIBELA, M.T.C.P.; SUZUKI, M.F.; GUIMARAES, M.I.C.C.; BUCHPIGUEL, C.A.; BARTOLINI, P.; OKAZAKI, K.
Comparison of the cytogenetic effects of sup(131)I in patients with differentiated thyroid cancer with and without prior treatment with rhtsh
2013 - VALGODE, FLAVIA G.S.; SILVA, MARCIA A. da; GONZALEZ, JULIA A.; YORIYAZ, HELIO; GUIMARAES, MARIA I.C.C.; RIBELA, MARIA T. de C.P.; BUCHPIGUEL, CARLOS A.; BARTOLINI, PAOLO; OKAZAKI, KAYO
Monte Carlo simulation for dose determination in thyroid cancer patients
2002 - YORIYAZ, H.; GUIMARAES, M.I.C.C.
Evaluation of the potential absorbed doses from patients based on whole-body sup(131)I clearance in thyroid cancer therapy
2006 - WILLEGAIGNON, JOSE; STABIN, MICHAEL G.; GUIMARAES, MARIA I.C.; MALVESTITI, LUIZ F.; SAPIENZA, MARCELO T.; MARONE, MARILIA; SORDI, GIAN M.A.A.
sup(131) I effective Half-Life (Tsub(eff)) for patients with thyroid cancer
2006 - WILLEGAIGNON, JOSE; MALVESTITI, LUIZ F.; GUIMARAES, MARIA I.C.; SAPIENZA, MARCELO T.; ENDO, IRENE S.; NETO, GUILHERME C.; MARONE, MARILIA; SORDI, GIAN MARIA A.A.